EGFR mutant status and tyrosine-kinase inhibitors affect the GKRS outcomes for NSCLC brain metastases-Reference-Cited by-同舟云学术

EGFR mutant status and tyrosine-kinase inhibitors affect the GKRS outcomes for NSCLC brain metastases

Published:2022-08-17 Issue:3 Volume:159 Page:675-684
ISSN:0167-594X
Container-title:Journal of Neuro-Oncology
language:en
Short-container-title:J Neurooncol

Author:

Liao Hung-Ruei,Chiang Chi-Lu,Shen Chia-I.,Chen Ching-Jen,Yang Huai-Che,Wu Hsiu-Mei,Luo Yung-Hung,Hu Yong-Sin,Lin Chung-Jung,Chung Wen-Yuh,Shiau Cheng-Ying,Guo Wan-Yuo,Pan David Hung-Chi,Lee Cheng-Chia

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Neurology (clinical),Neurology,Oncology

Link

https://link.springer.com/content/pdf/10.1007/s11060-022-04110-8.pdf

Reference41 articles.

1. Park HS, Decker RH, Wilson LD, James BY (2015) Prophylactic cranial irradiation for patients with locally advanced non–small-cell lung cancer at high risk for brain metastases. Clin Lung Cancer 16:292–297

2. Han G et al (2016) A retrospective analysis in patients with EGFR-mutant lung adenocarcinoma: is EGFR mutation associated with a higher incidence of brain metastasis? Oncotarget 7:56998

3. Miyawaki E et al (2019) Optimal sequence of local and EGFR-TKI therapy for EGFR-mutant non-small cell lung cancer with brain metastases stratified by number of brain metastases. Int J Radiat Oncol Biol Phys 104:604–613

4. Magnuson WJ et al (2016) Impact of deferring radiation therapy in patients with epidermal growth factor receptor–mutant non-small cell lung cancer who develop brain metastases. Int J Radiat Oncol Biol Phys 95:673–679

5. Wang W, Song Z, Zhang Y (2018) Efficacy of brain radiotherapy plus EGFR-TKI for EGFR-mutated non-small cell lung cancer patients who develop brain metastasis. Arch Med Sci 14:1298

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management strategies for intracranial progression in ALK-positive non-small cell lung cancer: a real-world cohort study;Journal of Neuro-Oncology;2023-12